{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:46Z","timestamp":1792798546273,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270346"],"award-info":[{"award-number":["82270346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370482"],"award-info":[{"award-number":["82370482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301368"],"award-info":[{"award-number":["82301368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116170","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T16:17:36Z","timestamp":1711469856000},"page":"116170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE -\/- mice"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5005-3150","authenticated-orcid":false,"given":"Keyin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusanjan","family":"Matniyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghuang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-0797","authenticated-orcid":false,"given":"Wenxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongJin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116170_b0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41569-020-00472-6","article-title":"Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes","volume":"18","author":"Bossone","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2024.116170_b0010","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/nrdp.2016.53","article-title":"Aortic dissection","volume":"2","author":"Nienaber","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2024.116170_b0015","article-title":"Acute aortic dissection: Pathogenesis, risk factors and diagnosis","volume":"147","author":"Gawinecka","year":"2017","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.bcp.2024.116170_b0020","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116170_b0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2015.05.029","article-title":"Presentation, diagnosis, and outcomes of acute aortic dissection: 17-Year trends from the international registry of acute aortic dissection","volume":"66","author":"Pape","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116170_b0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/eurheartj\/ehi024","article-title":"Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients","volume":"26","author":"Chiappini","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116170_b0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41421-021-00363-1","article-title":"Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm","volume":"8","author":"Jia","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.bcp.2024.116170_b0040","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ymthe.2021.09.017","article-title":"Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation","volume":"30","author":"Song","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2024.116170_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116170_b0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage Polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bcp.2024.116170_b0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2024.116170_b0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/ATVBAHA.117.310333","article-title":"IL-1\u03b2 (interleukin-1\u03b2) and TNF-\u03b1 (tumor necrosis factor-\u03b1) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization","volume":"38","author":"Batra","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2024.116170_b0065","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1172\/JCI38308","article-title":"An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice","volume":"119","author":"Tieu","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2024.116170_b0070","doi-asserted-by":"crossref","first-page":"e002413","DOI":"10.1161\/CIRCGEN.118.002413","article-title":"Interleukin-6 receptor signaling and abdominal aortic aneurysm growth rates","volume":"12","author":"Paige","year":"2019","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.bcp.2024.116170_b0075","unstructured":"R. Gurung, A.M. Choong, C.C. Woo, R. Foo, V. Sorokin. Genetic and epigenetic mechanisms underlying vascular smooth muscle cell phenotypic modulation in abdominal aortic aneurysm. Int. J. Mol. Sci. 212020."},{"key":"10.1016\/j.bcp.2024.116170_b0080","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/heartjnl-2014-305648","article-title":"Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies","volume":"100","author":"Davis","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.bcp.2024.116170_b0085","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116170_b0090","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116170_b0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116170_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.peptides.2013.12.015","article-title":"A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis","volume":"54","author":"Tashiro","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2024.116170_b0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-8587(19)30422-X","article-title":"Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map","volume":"8","author":"Zhu","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116170_b0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2019.00537","article-title":"The Glp-1 analog liraglutide protects against angiotensin II and pressure overload-induced Cardiac hypertrophy via PI3K\/Akt1 and AMPKa signaling","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116170_b0115","article-title":"Liraglutide attenuates hepatic ischemia-reperfusion injury by modulating macrophage polarization","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2024.116170_b0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12933-017-0626-3","article-title":"Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis","volume":"16","author":"Bruen","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116170_b0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ki.2013.427","article-title":"The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential","volume":"85","author":"Fujita","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116170_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2024.116170_b0135","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116170_b0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116170_b0145","doi-asserted-by":"crossref","first-page":"5568159","DOI":"10.1155\/2021\/5568159","article-title":"Effect of GLP-1\/GLP-1R on the polarization of macrophages in the occurrence and development of atherosclerosis","volume":"2021","author":"Yang","year":"2021","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2024.116170_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-021-00362-2","article-title":"Single-cell RNA sequencing identifies an Il1rn(+)\/Trem1(+) macrophage subpopulation as a cellular target for mitigating the progression of thoracic aortic aneurysm and dissection","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.bcp.2024.116170_b0155","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1161\/CIRCRESAHA.122.321722","article-title":"ADAR1 non-editing function in macrophage activation and abdominal aortic aneurysm","volume":"132","author":"Cai","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2024.116170_b0160","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jvs.2012.05.084","article-title":"Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissection","volume":"56","author":"Wang","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.bcp.2024.116170_b0165","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116170_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101249","article-title":"Research progress on the pathogenesis of aortic dissection","volume":"48","author":"Yin","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.bcp.2024.116170_b0175","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s42003-022-04255-2","article-title":"Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1\u03b2\/STAT3 signaling","volume":"5","author":"Xue","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2024.116170_b0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fphys.2020.00054","article-title":"The role of macrophages in aortic dissection","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2024.116170_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216042","article-title":"Inhibition of the PI3K\/AKT\/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma","volume":"555","author":"Palombo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2024.116170_b0190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phrs.2013.07.005","article-title":"Long-term liraglutide treatment is associated with increased insulin content and secretion in \u03b2-cells, and a loss of \u03b1-cells in ZDF rats","volume":"76","author":"Schwasinger-Schmidt","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2024.116170_b0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","article-title":"Liraglutide in type 2 diabetes mellitus: Clinical pharmacokinetics and pharmacodynamics","volume":"55","author":"Jacobsen","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2024.116170_b0200","unstructured":"C. Gellatly, M. Sweeting, A. Emin, et al.: Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth. Br. J. Surg. 1112024."},{"key":"10.1016\/j.bcp.2024.116170_b0205","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/dom.12858","article-title":"Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes","volume":"19","author":"Kramer","year":"2017","journal-title":"Diabetes Obes. Metab."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2024.116707","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T12:19:25Z","timestamp":1734783565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"alternative-id":["S0006295224001539"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116170","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcp.2024.116707","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE -\/- mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116170"}}